Publications
The effects of NMDA receptor antagonists on acute morphine antinociception in mice.
E Kozela, P Popik
Amino acids,
PMID:12373532
Wednesday, 9 October 2002
Amino acids,
PMID:12373532
Wednesday, 9 October 2002
Colostrinin and colostrinin-derived nonapeptide (colostral-val nonapeptide, CVNP) facilitate learning and memory in rats.
P Popik
Polish journal of pharmacology,
PMID:11787957
Friday, 11 January 2002
Polish journal of pharmacology,
PMID:11787957
Friday, 11 January 2002
Anxiogenic action of ibogaine.
P Popik, M Wróbel
The Alkaloids. Chemistry and biology,
PMID:11705110
Tuesday, 13 November 2001
The Alkaloids. Chemistry and biology,
PMID:11705110
Tuesday, 13 November 2001
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
A Bisaga, S D Comer, A S Ward, P Popik, H D Kleber, M W Fischman
Psychopharmacology,
PMID:11512037
Monday, 20 August 2001
Psychopharmacology,
PMID:11512037
Monday, 20 August 2001
Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats.
E Kozela, W Danysz, P Popik
European journal of pharmacology,
PMID:11438302
Wednesday, 4 July 2001
European journal of pharmacology,
PMID:11438302
Wednesday, 4 July 2001
Cognitive effects of Colostral-Val nonapeptide in aged rats.
P Popik, Z Galoch, M Janusz, J Lisowski, J Vetulani
Behavioural brain research,
PMID:11164518
Thursday, 22 February 2001
Behavioural brain research,
PMID:11164518
Thursday, 22 February 2001
[Contemporary methods in pharmacotherapy in the opiate dependent treatment].
M Radomska, A Bisaga, P Popik
Przegla̧d lekarski,
PMID:11199877
Tuesday, 30 January 2001
Przegla̧d lekarski,
PMID:11199877
Tuesday, 30 January 2001
Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders.
A Bisaga, P Popik, A Y Bespalov, W Danysz
Expert opinion on investigational drugs,
PMID:11060803
Tuesday, 12 December 2000
Expert opinion on investigational drugs,
PMID:11060803
Tuesday, 12 December 2000
Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence.
P Popik, M Wróbel, G Nowak
Neuropharmacology,
PMID:10974311
Monday, 13 November 2000
Neuropharmacology,
PMID:10974311
Monday, 13 November 2000
Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice.
P Popik, E Kozela, A Pilc
British journal of pharmacology,
PMID:10903986
Wednesday, 13 September 2000
British journal of pharmacology,
PMID:10903986
Wednesday, 13 September 2000